Bioqual (OTCMKTS:BIOQ) Releases Earnings Results

Bioqual (OTCMKTS:BIOQ) issued its earnings results on Tuesday. The company reported ($1.36) EPS for the quarter, Zacks reports. Bioqual had a negative return on equity of 2.87% and a negative net margin of 1.99%.

Bioqual Stock Performance

OTCMKTS BIOQ remained flat at $65.00 during trading on Tuesday. Bioqual has a 1 year low of $65.00 and a 1 year high of $80.00. The firm’s fifty day simple moving average is $66.56 and its two-hundred day simple moving average is $68.52. The stock has a market cap of $57.85 million, a PE ratio of -52.85 and a beta of -0.33.

Bioqual Company Profile

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.